bluuebunny/crossref_metadata_2025_split huggingface dataset:
Female participation in U.S. oncology clinical trials registered on ClinicalTrials.gov from 2008 to 2020.
Authors: Perera Nirosha D. , Bellomo Tiffany R. , Litt Henry K. , Fattahi Sayeh , Bell Alexander , Stavins MaKenna A. , Saleki Massoud , Ionescu Ruxandra , Shyu Margaret , Wang Max M. , Tao Jacqueline , Sarsour Nadeen , Ji Sunjong , O'Keefe Ryan M , Pun Matthew , Takasugi Jordan M. , Steinberg Jecca R. , King Roderick , Mahipal Amit , Turner Brandon E. 
Published: September 2021

85 Background: Females are thought to be underrepresented in clinical trials, which may lead to care disparities. We characterized female enrollment trends in U.S. oncology trials registered on ClinicalTrials.gov and identified features associated with accurate representation. Methods: We employed a cross-sectional study design with descriptive, logistic regression, and cox regression analyses. We downloaded 270,172 studies registered on the Aggregate Analysis of the ClinicalTrials.gov database from October 1, 2008 to March 9, 2020, excluding non-interventional and reproductive organ specific trials. We then applied cancer/oncology specific Medical Subject Heading terms and manually reviewed the remaining 27,521 trials for true oncology content. Prevalence-corrected estimates for female participation were calculated as the percentage of females among trial participants divided by the percentage of females in the disease population per U.S. Surveillance, Epidemiology, and End Results Program (SEER) data (participation to prevalence ratio [PPR]), with a range between 0.8 and 1.2 reflecting accurate female representation in the trial. Results: Of 26,894 trials meeting eligibility criteria, 9,059 trials were completed in the U.S., 2,499 trials reported completed study status, and only 1,256 trials reported sex. Among 1,256 oncology trials and 229,056 participants, overall female representation was 46.9% (95% CI, 45.4-48.4%). 43% of trials were industry funded, 29% academic, and 28% U.S. government. Females were underrepresented compared to their disease burden in anal canal (PPR 0.21), thyroid (PPR 0.57), stomach (PPR 0.68), kidney (PPR 0.77), and bone (PPR 0.79) cancer trials. They were accurately represented in head and neck (PPR 0.80), lung (PPR 0.84), bladder (PPR 0.85), skin (PPR 0.88), pancreas (PPR 0.88), colon (PPR 0.90), hematologic (PPR 0.91), liver (PPR 1.01), CNS (PPR 1.03), soft tissue (PPR 1.05), and esophagus (PPR 1.05) cancer trials. Accurate representation was significantly associated with industry funding and pancreas cancer trial focus, but not associated with trial type (medical, surgical, radiation, other invasive, other) (Table). Conclusions: Females are underrepresented compared to their disease burden in many solid tumor clinical trials. Stakeholders can look to industry funded and pancreas cancer trials as models of improvement, but must increase female representation in clinical trials to improve cancer care. [Table: see text]
Financial toxicity, symptom burden, illness perceptions, and communication confidence in cancer clinical trial participants.
Authors: Perni Subha , Azoba Chukwuma , Gorton Emily , Park Elyse R. , Chabner Bruce Allan , Moy Beverly , Nipp Ryan David 
Published: September 2021

86 Background: Cancer clinical trial (CCT) participants are at risk for experiencing adverse effects from financial toxicity, yet these remain understudied. We sought to describe associations among CCT participant-reported financial toxicity (financial burden [FB] and trial cost concerns), symptoms, illness perceptions, communication confidence, hospitalizations, and survival. Methods: From 7/2015-7/2017, we prospectively enrolled CCT participants who expressed interest in financial assistance (n = 100) and a patient group matched by age, sex, cancer type, specific trial, and trial phase (n = 98). We assessed FB (burdened by costs of cancer care), trial cost concerns (worried about affording medical costs of a CCT), physical (Edmonton Symptom Assessment Scale [ESAS]) and psychological (Patient Health Questionnaire-4 [PHQ-4]) symptoms, illness perceptions (Brief Illness Perception Questionnaire [BIPQ]), and communication confidence (Perceived Efficacy in Patient-Physician Interactions [PEPPI]). We used regression models to explore sociodemographic associations with FB and trial cost concerns, as well as their associations with symptom burden, illness perceptions, and communication confidence, adjusting for age, sex, race, performance status, marital status, and metastatic status. We also used Kaplan-Meier and regression methods to evaluate their associations with 6-month hospitalizations and survival. Results: Of 198 patients enrolled, 112 (56.6%) reported FB and 82 (41.4%) had trial cost concerns. Patients with FB were younger (OR 0.96, 95% CI 0.94-0.98) with lower incomes (< $100,000, OR 4.61, 95% CI 2.35-9.01). Patients with trial cost concerns had lower incomes (< $100,000, OR 2.78, 95% CI 1.45-5.29). On adjusted analyses, patients with FB had higher ESAS (OR 1.03, 95% CI 1.02-1.05), PHQ-4 depression (OR 1.54, 95% CI 1.22-1.94), and PHQ-4 anxiety (OR 1.30, 95% CI 1.08-1.55) scores, as well as more negative illness perceptions (OR 1.04, 95% CI 1.01-1.07), but no significant difference in communication confidence (OR 0.98, 95% CI 0.93-1.05). Patients reporting trial cost concerns had higher ESAS (OR 1.03, 95% CI 1.01-1.05), PHQ-4 depression (OR 1.35, 95% CI 1.10-1.65), and PHQ-4 anxiety (OR 1.27, 95% CI 1.07-1.51) scores, as well as more negative illness perceptions (OR 1.06, 95% CI 1.03-1.10), and lower communication confidence (OR 0.93, 95% CI 0.87-0.99). Financial toxicity was not significantly associated with hospitalizations or survival. Conclusions: In this study of CCT participants, younger patients with lower incomes were most vulnerable to financial toxicity. Financial toxicity was associated with greater symptoms, more negative illness perceptions, and lower communication confidence, underscoring the importance of addressing these issues when seeking to alleviate the adverse effects of financial toxicity in CCT participants.
The impact of race, education, and employment status on cost-coping strategies and patient reported benefit from interventions to mitigate financial toxicity.
Authors: Braxton Kenya , Thom Bridgette , Brown Carol L. , Gany Francesca , Chino Fumiko , Aviki Emeline Mariam 
Published: September 2021

91 Background: As patient financial toxicity increases with the cost of cancer healthcare, patient outcomes and quality of life may be impaired. We sought to evaluate sociodemographic factors associated with use of cost-coping strategies, as well as strategies to mitigate financial toxicity. Methods: We conducted a survey of consecutive patients in an urban outpatient gynecologic cancer clinic waiting room over 2 weeks in August 2019. The survey included patient demographics, disease characteristics, the Comprehensive Score for Financial Toxicity (COST; scored 0-44, lower scores indicate worse outcomes), assessment of cost-coping strategies, and patient-reported anticipated benefit from possible interventions. Patients were categorized by race/ethnicity (non-Hispanic white, Hispanic white, black, Asian, other) and employment and education status. Kruskal-Wallis and Fisher’s exact tests were used to assess differences between groups. Results: Of 101 patients, 75 completed the survey. Most patients were non-Hispanic white (60%), retired (45%), and had at minimum a bachelor’s degree (65%). The median COST score was 32 (range 6-44). For cost-coping strategies, among renters (n=48), black and other race patients compared to white patients more often indicated skipping a rent payment (25% and 50% vs 0%; p<.01). Employed patients compared to retired patients more often indicated reducing leisure spending (58% vs 27%; p=.02). Patients with less than a bachelor’s degree compared to those with a bachelor’s degree or higher more often indicated borrowing money to pay for medical bills (24% vs 6%; p=.04). For proposed interventions to lessen financial toxicity, non-Hispanic white and Asian patients compared to black patients more often indicated they wanted to know the cost of their healthcare upfront (38% and 33% vs 0%; p =.26). Employed patients compared to unemployed and retired patients more often indicated that minimizing copays would be beneficial (36% vs 13% and 12%, p=.05). Patients with less than a bachelor’s degree compared to those with a bachelor’s degree or higher more often indicated that transportation assistance would be helpful (76% vs 24%; p<.01). Conclusions: As the needs of different sociodemographic groups vary, so do their cost-coping strategies and preferred interventions to ameliorate financial toxicity. Varying patient needs should be considered when developing interventions to mitigate financial toxicity. Next steps should assess the benefit of targeted interventions on coping strategies in specific sociodemographic groups.
Evaluating the user-perceived benefit of a virtual patient education and support community: LVNG With Lung Cancer.
Authors: Martin Mona L. , Bucklen Kristin , Hall Lise J. , Sandy Beth , Wonser Dann , de Renne Genevieve 
Published: September 2021

92 Background: The accessibility and quality of network support for people living with lung cancer (PLW) and their support partners (SP) can vary. Virtual platforms provide a unique opportunity for PLW/SP peer support and disease education; the challenge is to measure impact. Methods: Our aim was to determine user-perceived benefit of the Facebook-based virtual community LVNG With Lung Cancer ( https://www.facebook.com/LVNGWithLungCancerUS ). Qualitative interviews were conducted with community members aged ≥18 yrs and living with lung cancer or actively supporting someone who had lung cancer. Also, inbound community comments (Dec 2015–Oct 2016) were retrospectively analyzed and grouped by similarity of content. Results: 18 PLW and 2 SP were interviewed (N = 20, saturation of concept met within the first 10). Mean yrs since diagnosis was 2.75 (range 0.08–17). Of the total expressions of benefit (n = 513) made during the interviews, 32% focused on increased health knowledge, with most participants calling out cancer information, good health behaviors, and coping strategies as key community benefits. Social impacts of the community accounted for 28% of benefit expressions; having a forum to share experiences and having a supportive environment were most frequently cited. An additional 18% of benefit expressions revealed that the community gives members feelings of empowerment, including feeling less alone (55% of respondents) and feeling inspired to help others (40% of respondents). Benefits received from community membership led to behavioral change in many respondents: 55% asked their doctor more questions, 50% shared helpful experiences with other members, and 35% took a more active role in their healthcare. In a notable example, an SP member said the community provided her with the knowledge she needed to address her symptoms and fears with her doctor, who was hesitant to biopsy because she did not meet typical risk criteria. Her self-advocacy was successful and ultimately led to an early lung cancer diagnosis. Results from the retrospective analysis of actual postings (n = 24,336; all unique users during evaluation period: n = 12,187) reflected the themes patients offered during interviews as important reasons to participate: 63% of postings were asking for or sharing cancer information, 98% provided emotional support and/or understanding, and 84% were inspirational/optimistic. Conclusions: This dual approach of assessing real-world impact of a virtual Facebook community provided insight into the benefit that members derive and highlighted the integral role of support groups in patient-centric care. Importantly, once members’ emotional and educational needs were met, they were empowered and/or inspired to take positive actions leading to better health behaviors and increased quality of life – an outcome that may have wider applicability for diseases beyond lung cancer.
Overall survival benefits of advances in NSCLC systemic treatments: Younger versus older adults.
Authors: Leung Bonnie , Shokoohi Aria , Al-Hashami Zamzam Salam , Moore Sara , Pender Alexandra , Wong Selina K. , Wang Ying , Wu Jonn , Ho Cheryl 
Published: September 2021

93 Background: Historically, there has been limited systemic therapy options for older adults with cancer attributed to underlying frailty, co-morbidities, poor functional status, and limited social supports. In the past decade, treatment for advanced NSCLC has changed with increasing availability of novel therapeutics associated with improved tolerability and efficacy, such as targeted therapy and immunotherapy. The study goal is to compare the difference in overall survival (OS) between younger adults and older adults with the introduction of novel therapeutic options. Methods: All patients with stage IV NSCLC referred to BC Cancer in 2009, 2011, 2015 and 2017 were included in the study. One-year time points were chosen based on molecular testing implementation and provincial formulary listing: baseline (2009), EGFR testing (2011), ALK testing (2015) and immunotherapy listing (2017). Age was categorized as younger (< 70 years) and older (≥70 years) adults. Baseline demographics, simplified comorbidity score (SCS ≥9 associated with poor prognosis), disease characteristics, and systemic therapy details (agent, duration, line of therapy) were collected retrospectively. Univariate analysis using X2 and Fisher’s exact tests were used to compare age groups. OS was calculated using the Kaplan-Meier method and compared using the log-rank test. Results: 3325 patients with stage IV NSCLC were identified. Baseline characteristics for patients < 70 y; female 51%, non-squamous 62%, ECOG ≥2 50%, SCS ≥9 29% vs patients ≥70 y; female 49%, non-squamous 57%, ECOG ≥2 61%, SCS ≥9 58%. In the four time cohorts 2009/2011/2015/2017, systemic treatment was delivered to < 70 y 44/53/51/52 % vs ≥70 y 23/25/28/30 %. Median OS with BSC for < 70 y 3.1/2.8/2.8/2.5 m vs ≥70 y 3.8/3.3/3.4/3.1 m (p = 0.10). Median OS with systemic treatment for < 70 y 9.0/10.9/13.9/15.5 m (p < 0.001) vs ≥70 y 11.4/11.7/13.9/14.9 m (p < 0.001). Median OS by type of treatment BSC/chemotherapy only/targeted therapy/immunotherapy; < 70 y 2.8/8.9/21.4/20.2 m vs ≥70 y 3.1/10.1/21.5/20.1 m (p < 0.001). Conclusions: In this real-world retrospective review of patients with advanced NSCLC, there was an increased uptake of systemic therapy for both age groups with the introduction of novel therapeutics. Although there was a smaller proportion of older adults who received systemic therapy, those who received treatment had comparable OS to their young counterpart. The benefit of systemic therapy in both age groups was seen across the different types of treatments. This suggests with careful assessment and selection of appropriate candidates, older adults with advanced NSCLC should receive equitable access to systemic therapy.
Nature's Wild
Authors: Gosine Andil 
Published: September 2021

In Nature's Wild, Andil Gosine engages with questions of humanism, queer theory, and animality to examine and revise understandings of queer desire in the Caribbean. Surveying colonial law, visual art practices, and contemporary activism, Gosine shows how the very concept of homosexuality in the Caribbean (and in the Americas more broadly) has been overdetermined by a colonially influenced human/animal divide. Gosine refutes this presupposed binary and embraces animality through a series of case studies: a homoerotic game called puhngah, the institution of gender-based dress codes in Guyana, and efforts toward the decriminalization of sodomy in Trinidad and Tobago—including the work of famed activist Colin Robinson, paintings of human animality by Guadeloupean artist Kelly Sinnapah Mary, and Gosine's own artistic practice. In so doing, he troubles the ways in which individual and collective anxieties about “wild natures” have shaped the existence of Caribbean people while calling for a reassessment of what political liberation might look like.
&gt;Duke University Press Scholars of Color First Book Award recipient
SureTypeSCR: R package for rapid quality control and genotyping of SNP arrays from single cells
Authors: Vogel Ivan , Cai Lishan , Jerman-Plesec Lea , Hoffmann Eva R. 
Published: September 2021

Genotyping of single cells using single nucleotide polymorphism arrays is a cost-effective technology that provides good coverage and precision, but requires whole genome amplification (WGA) due to the low amount of genetic material. Since WGA introduces noise, we recently developed SureTypeSC, an algorithm to minimize genotyping errors. Here, we present SureTypeSCR, an R package that integrates a state-of-the-art algorithm (SureTypeSC) for noise reduction in single cell genotyping and unites all common parts of genotyping workflow in a single tool. SureTypeSCR is built on top of the tidyverse ecosystem, which facilitates common operations over the data and allows users to create and experiment with the genotyping pipeline. Furthermore, the workflow of SureTypeSCR can also be used for standard genotyping of bulk DNA for batch processing in a single pipeline. SureTypeSCR is avaliable from: https://github.com/Meiomap/SureTypeSCR
Hematologic and coagulopathy parameter as a survival predictor among moderate to severe COVID-19 patients in non- ICU ward: a single-center study at the main referral hospital in Surabaya, East Java, Indonesia
Authors: Bintoro Siprianus Ugroseno Yudho , Dwijayanti Ni Made Intan , Pramudya Dana , Amrita Putu Niken , Romadhon Pradana Zaky , Asmarawati Tri Pudy , Bachtiar Arief , Hadi Usman 
Published: September 2021

Background : This research aimed to examine and analyze risk factors for death, hematologic parameters and coagulation in COVID-19 patients at RSUD Dr. Soetomo Surabaya, one of the referral centers for probable COVID-19 patient cases in East Java. Method : This was a retrospective analytical study by taking secondary data on patients with probable COVID-19 cases who were treated in hospital isolation rooms from May to September, 2020. Result : Of 538 probable COVID-19 patients, 217 tested positive, with an average age of 52.11±13.12 years, and there were 38 death cases. Hematologic parameters, such as white blood cell, neutrophil and lymphocyte counts, were significantly different in the deceased group. On the other hand, coagulation parameters, consisting of D-dimer, CRP, PT, and aPTT showed significantly similar value in the deceased group. Univatiate analysis concluded that chronic kidney disease, diabetes mellitus, coronary heart disease, WBC, NLR, and PPT counts could predict the mortality, while multivariate analysis revealed that coronary heart disease was the only significant independent predictor of mortality. Conclusion : This research shows that hematologic and coagulation parameters were increased in the majority of COVID-19 patients and the deceased group. While the number of neutrophils and WBC increases, the number of lymphocytes decreases significantly with increasing disease severity. Coronary heart disease is an independent predictor of mortality.
Dermatoglyphics and abdominal resistance in female children and adolescents: a cross-sectional study
Authors: Souza Renan , Alberti Adriano , Gastélum Cuadras Gabriel , de Souza Vale Rodrigo Gomes , Marcio Zanoni Eliton , Benetti Zavorski Eloel , Aparecida De Jesus Josiane , Hur Soares Ben , Pertille Fabiane , Fin Gracielle , Becker da Silva Bruna , R. Grigollo Leoberto , D. Schlindwein Aline , Freiberger Viviane , Ventura Leticia , Quadros Luana , Alfonso González Rivas Ramón , Núñez Enríquez Oscar , Islas Guerra Samuel Alfredo , Valenzuela Jurado Felipe , Iván Chávez Erives Arturo , Martínez Treviz Arturo , Arnoldo García Fernández David , Marques Leão Graziela , Comim Clarissa Martinelli , Nodari Junior Rudy José 
Published: September 2021

Background: Dermatoglyphics is considered, in the scientific milieu, to be an epigenetic marker. The objective of this study was to analyze the presence of dermatoglyphic marks characteristic of neuromotor capacity and abdominal resistance in children and adolescents. Methods: This is a cross-sectional study. The sample consisted of 1,002 individuals, female children and adolescents between the ages of 10 and 16, from public and private schools in the city of Joaçaba, Santa Catarina, Brazil. The protocol selected for analyzing the fingerprints was dermatoglyphics, proposed by Cummins and Midlo using a Dermatoglyphic Reader. The Brazilian Sports Project Manual - PROESP 2015 was used to collect data on muscle strength motor tests. Results: The results showed the presence of a dermatoglyphic mark characteristic of abdominal motor capacity and muscle strength in females. A higher frequency of arches was identified in MET4 and whorls in MET5 and MDT4 in the Risk Zone group. In the Healthy Zone group, ulnar loop was found to be more frequent in MET4, MET5, and MDT4 fingers. Conclusions: The results demonstrated a predictive marker for abdominal motor capacity and strength in females through dermatoglyphics.
Effects of F/2 media modification on growth and antioxidant activity of microalga Nannochloropsis oculata
Authors: Ghafari Mohammad Aulia , Suryaningtyas Indyaswan Tegar , Yona Defri , Sapulete Serly , Tarmin Nurhalis , Ali La , Marzuki Ramli , Pangestuti Ratih 
Published: September 2021

Nannochloropsis oculata is a common microalga that can be found in marine water. One of the most commonly used media for microalga culture is F/2 media; however, the optimum F/2 media composition for N. oculata growth is rarely informed. Therefore, the aims of this study are to determine the effect of F/2 medium modification on the growth of N. oculata and the antioxidant activity of N. oculata. This study consists of several procedures including; cultivation, growth observation (cell density and biomass), extraction, and antioxidant activity of N. oculata extracts. The highest growth (cell density and biomass) of N. oculata was found in media F/2 + 0.5 ml, while the lowest was in media F/2 - 0.5 ml. The strongest antioxidant activity of N. oculata was found in media F/2 + 1 ml, and the lowest was in the media F/2 - 0.5 ml. Media modification gave different results on cell density, biomass, and antioxidant activity of microalgae N. oculata.
Ritualzeit – Zeitwahrnehmungen und Zeitpraktiken am Hof um 1000
Authors: Schley Daniel 
Published: September 2021

Abstract
A notable feature of courtly life in Japan were its ritualized procedures, which not only included periodical religious ceremonies but also political activities. Time at the court was of the essence for its ceremonial routine. Yet how did courtiers perceive their daily occupations in temporal regards, and to what extent did they evaluate their personal time, while the communal time was objectively measured and pronounced? How did those involved in courtly ceremonies encounter time in terms of its availability and its symbolic qualities, e.g. bemoaning a lack of time or adjusting to auspicious as well as ominous dates? Research so far has provided a profound understanding of time calculations, the courtly ritual calendar and especially the divination office, whose task it was to determine favourable days for the various activities at the court. In contrast, concrete political and religious acts at court have received less consideration as temporal processes. In order to find some answers to the outlined questions, I will focus on rituals as a case study of conceptions and practises of time. Information on courtiers’ dealings with their individual as well as social time can be obtained from various sources, among which I examine courtly diaries, with a special focus on Fujiwara no Yukinari’s diary Gonki. The author’s statements about time will help to elucidate some temporal aspects of courtly rituals as well as to deepen our knowledge of time perceptions at the Japanese court during its heydays.